Literature DB >> 26615593

MRI T2 characteristics in somatotroph adenomas following somatostatin analog treatment in acromegaly.

Ansgar Heck1,2, Kyrre E Emblem3, Olivera Casar-Borota4,5, Geir Ringstad6, Jens Bollerslev7,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26615593     DOI： 10.1007/s12020-015-0816-2

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  10 in total

1.  Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation.

Authors:  Akira Hagiwara; Yuichi Inoue; Kenichi Wakasa; Tomoko Haba; Takahiko Tashiro; Takeshi Miyamoto
Journal:  Radiology       Date:  2003-06-20       Impact factor: 11.105

2.  Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly.

Authors:  Ansgar Heck; Geir Ringstad; Stine L Fougner; Olivera Casar-Borota; Terje Nome; Jon Ramm-Pettersen; Jens Bollerslev
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

3.  A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors.

Authors:  Sylvia L Asa; Rebecca Digiovanni; Jing Jiang; Megan L Ward; Kimberly Loesch; Shozo Yamada; Toshiaki Sano; Katsuhiko Yoshimoto; Stuart J Frank; Shereen Ezzat
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

4.  Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly.

Authors:  Ansgar Heck; Kyrre E Emblem; Olivera Casar-Borota; Jens Bollerslev; Geir Ringstad
Journal:  Endocrine       Date:  2015-10-16       Impact factor: 3.633

5.  Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure.

Authors:  Manel Puig-Domingo; Eugenia Resmini; Beatriz Gomez-Anson; Joana Nicolau; Mireia Mora; Elisabet Palomera; Camelia Martí; Irene Halperin; Susan M Webb
Journal:  J Clin Endocrinol Metab       Date:  2010-08-25       Impact factor: 5.958

6.  Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequences.

Authors:  Iulia Potorac; Patrick Petrossians; Adrian F Daly; Franck Schillo; Claude Ben Slama; Sonia Nagi; Mouna Sahnoun; Thierry Brue; Nadine Girard; Philippe Chanson; Ghaidaa Nasser; Philippe Caron; Fabrice Bonneville; Gérald Raverot; Véronique Lapras; François Cotton; Brigitte Delemer; Brigitte Higel; Anne Boulin; Stéphan Gaillard; Florina Luca; Bernard Goichot; Jean-Louis Dietemann; Albert Beckers; Jean-François Bonneville
Journal:  Endocr Relat Cancer       Date:  2015-01-02       Impact factor: 5.678

7.  Acromegaly: an endocrine society clinical practice guideline.

Authors:  Laurence Katznelson; Edward R Laws; Shlomo Melmed; Mark E Molitch; Mohammad Hassan Murad; Andrea Utz; John A H Wass
Journal:  J Clin Endocrinol Metab       Date:  2014-10-30       Impact factor: 5.958

8.  Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in somatotroph adenomas assessed by monoclonal antibodies was reduced by octreotide and correlated with the acute and long-term effects of octreotide.

Authors:  Olivera Casar-Borota; Ansgar Heck; Stefan Schulz; Jahn Marthin Nesland; Jon Ramm-Pettersen; Tove Lekva; Irina Alafuzoff; Jens Bollerslev
Journal:  J Clin Endocrinol Metab       Date:  2013-10-03       Impact factor: 5.958

9.  Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.

Authors:  Abdulkader Obari; Toshiaki Sano; Kenichi Ohyama; Eiji Kudo; Zhi Rong Qian; Akiko Yoneda; Nasim Rayhan; Muhammad Mustafizur Rahman; Shozo Yamada
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

Review 10.  Guidelines for acromegaly management: an update.

Authors:  S Melmed; A Colao; A Barkan; M Molitch; A B Grossman; D Kleinberg; D Clemmons; P Chanson; E Laws; J Schlechte; M L Vance; K Ho; A Giustina
Journal:  J Clin Endocrinol Metab       Date:  2009-02-10       Impact factor: 5.958
  10 in total
  7 in total

Review 1.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

2.  T2-weighted magnetic resonance imaging characterization of prolactinomas and association with their response to dopamine agonists.

Authors:  M C Burlacu; D Maiter; T Duprez; E Delgrange
Journal:  Endocrine       Date:  2018-09-28       Impact factor: 3.633

3.  Clinicopathological significance of baseline T2-weighted signal intensity in functional pituitary adenomas.

Authors:  Sema Ciftci Dogansen; Gulsah Yenidunya Yalin; Seher Tanrikulu; Sakin Tekin; Nihan Nizam; Bilge Bilgic; Serra Sencer; Sema Yarman
Journal:  Pituitary       Date:  2018-08       Impact factor: 4.107

4.  The therapeutic response of somatotropinomas according to the T2-weighted signal intensity on the MRI.

Authors:  Carla-Liana Scânteie; Daniel-Corneliu Leucuţa; Cristina Ghervan
Journal:  Med Pharm Rep       Date:  2021-10-30

5.  Clinical and Radiological Predictors of Biochemical Response to First-Line Treatment With Somatostatin Receptor Ligands in Acromegaly: A Real-Life Perspective.

Authors:  Federica Nista; Giuliana Corica; Lara Castelletti; Keyvan Khorrami; Claudia Campana; Francesco Cocchiara; Gabriele Zoppoli; Alessandro Prior; Diego Criminelli Rossi; Gianluigi Zona; Diego Ferone; Federico Gatto
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-07       Impact factor: 5.555

6.  Predicting Subtype of Growth Hormone Pituitary Adenoma based on Magnetic Resonance Imaging Characteristics.

Authors:  Chen-Xi Liu; Sheng-Zhong Wang; Li-Jun Heng; Yu Han; Yu-Hui Ma; Lin-Feng Yan; Ying Yu; Wen Wang; Yu-Chuan Hu; Guang-Bin Cui
Journal:  J Comput Assist Tomogr       Date:  2022 Jan-Feb 01       Impact factor: 1.826

7.  Usefulness of the Texture Signatures Based on Multiparametric MRI in Predicting Growth Hormone Pituitary Adenoma Subtypes.

Authors:  Chen-Xi Liu; Li-Jun Heng; Yu Han; Sheng-Zhong Wang; Lin-Feng Yan; Ying Yu; Jia-Liang Ren; Wen Wang; Yu-Chuan Hu; Guang-Bin Cui
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.